Mmegi

Pharmaceuticals present $190m opportunity for growth, innovation

Shot in the arm: The COVID-19 pandemic exposed the need for countries such as Botswana to bulk up their pharmaceutical sectors PIC:  VCU NEWS
Shot in the arm: The COVID-19 pandemic exposed the need for countries such as Botswana to bulk up their pharmaceutical sectors PIC: VCU NEWS

A study into the potential of developing a pharmaceutical industry in the country has found that strategic investments in policy, skills development, and harnessing the country’s rich biodiversity, could transform the infant sector into a regional powerhouse.

The study was developed last year by the Botswana Investment and Trade Centre (BITC) in partnership with the European Union’s Africa RISE (Reform for Investment and Sustainable Economies) programme.

The study aims to help Botswana develop its pharmaceutical manufacturing capabilities while boosting its competitiveness at both local and regional levels. The consultancy team included three local experts from the University of Botswana who worked alongside the BITC team, reporting to a diverse reference group that validated the findings.

Editor's Comment
Tana project a welcome development

Whilst the project received mixed reactions from members of the public, the project is indeed a welcome development, which needs to be implemented as soon as possible. Many shared their opinion, with those against the project decrying that if implemented, it will kill the already struggling public transport industry.Many countries around the world have state-run public transport, and those who have travelled to such countries will give testimony...

Have a Story? Send Us a tip
arrow up